icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Fri 23 Oct 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

Drug Clinical Trials List

Display 311 - 320 from 800
Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy Sanofi Completed Irbesartan Amlodipine 3 IRBAM_R_04219 NGHA-J
Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure. A Randomised Double-blind Placebo-controlled International Multicenter Study. Servier Terminated Ivabradine 3 CL3-16257-083 KFMC
Effects of Add on Pegylated Interferon therapy in patients of Chronic hepatitis B in maintained response with ongoing nucleos(t)ide analogues ; A multicenter, prospective, randomized open label trial. KAIMRC Ongoing PEGINTERFERON ALFA-2A, RO258310 RIBAVIRIN, R0209963 3 RC14-055-R NGHA-R
Effect of subcutaneous semaglutide 2.4 mg once-weekly compared to placebo in subjects with obesity and knee osteoarthritis Novo Nordisk Ongoing semaglutide 3 NN9536-4578 King Fahad Medical City (Riyadh)
Effect of Preoperative Administration of Ibuprofen in Children Undergoing Extraction for Reducing Postoperative Pain: A Double-blind Randomized Controlled Clinical Trial Princess Nourah University Completed ibuprofen 3 18-0253 PNU-CD
Effect of Gum Arabic supplementation on butyrate, uremic retention molecules and inflammation in chronic kidney disease patients King Fahad Specialist Hospital - Dammam / KACST Completed Gum Arabic / E-114 2 2 KFSH
Early administration of Tocilizumab in Immunocompromised and potential high-risk patients for developing COVID-19 King Faisal Specialist Hospital & Research Centre Completed TOCILIZUMAB 2 2201070 KFSH&RC-R
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG) KKUH Ongoing Heparin - Enoxaparin - Tinzaparin - Fondaparinux 3 1.2 King Khalid University Hospital (Riyadh)
"Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic ( RAPID COVID COAG) " KAIMRC Completed TINZAPARIN SODIUM 3 RC20/403 King Abdulaziz Medical City NG (Riyadh)
Circulating Endotoxin as a Contributing Inflammatory Mediator in Osteoporosis Risk and its Association with Vitamin D Deficiency National Plan for Science and Technology Ongoing Vitamin D3 VS. Alendronate 3 11-MED-2113-02 or (G1109-665) KFMC